 |
0 Diseases |  |
0 Trials |
|
0 Trials |  |
5 News |  |
- | ISIS-GCCRRx / Ionis
Trial completion: Safety, Tolerability and Efficacy of ISIS-GCCRRx in Type 2 Diabetes (clinicaltrials.gov) - May 13, 2015
P2, N=38, Completed, Sponsor: Isis Pharmaceuticals
Active, not recruiting --> Completed
- | ISIS-GCCRRx / Ionis
Enrollment closed: Safety, Tolerability and Efficacy of ISIS-GCCRRx in Type 2 Diabetes (clinicaltrials.gov) - Mar 5, 2015
P2, N=40, Active, not recruiting, Sponsor: Isis Pharmaceuticals
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- ISIS-GCCRRx / Ionis
Trial primary completion date: Safety, Tolerability and Efficacy of ISIS-GCCRRx in Type 2 Diabetes (clinicaltrials.gov) - Dec 5, 2014
P2, N=40, Recruiting, Sponsor: Isis Pharmaceuticals
Recruiting --> Active, not recruiting Trial primary completion date: Nov 2014 --> Feb 2015
- | ISIS-GCCRRx / Ionis
Enrollment open: Safety, Tolerability and Efficacy of ISIS-GCCRRx in Type 2 Diabetes (clinicaltrials.gov) - Oct 21, 2013
P2, N=40, Recruiting, Sponsor: Isis Pharmaceuticals
Trial primary completion date: Nov 2014 --> Feb 2015 Not yet recruiting --> Recruiting
- | ISIS-GCCRRx / Ionis
New P2 trial: Safety, Tolerability and Efficacy of ISIS-GCCRRx in Type 2 Diabetes (clinicaltrials.gov) - Oct 17, 2013
P2, N=40, Recruiting, Sponsor: Isis Pharmaceuticals